These data demonstrate that PDX-1 is significantly overexpressed in both human pancreatic neuroendocrine tumors, nesiodioblastosis and mouse islet neoplasia, suggesting it is a potential target for these diseases. This evidence concerns the gene PDX1 and pancreatic neuroendocrine tumor.